mrna-1893
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 30, 2019 (NCT04064905)
Timeline
Indications
Studied for
Mechanism of action
- Zika virusImmunity, active
immunity, active - zika virus
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04917861 | Phase 2 | Jun 8, 2021 | Moderna Therapeutics |
| NCT04064905 | Phase 1 | Jul 30, 2019 | Department of Health and Human Services, Moderna Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Moderna Therapeutics | For profit | 2 | 2 | 2 | 2019 |
| Department of Health and Human Services | Government | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1